ME/CFS Evidence Browser — Classified Studies on Myalgic Encephalomyelitis

61–80 of 214 studies

A randomised controlled trial of the monoaminergic stabiliser (-)-OSU6162 in treatment of myalgic encephalomyelitis/chronic fatigue syndrome.

Nilsson, Marie Karin Lena, Zachrisson, Olof, Gottfries, Carl-Gerhard et al.·Acta neuropsychiatrica·2018

Researchers tested a drug called (-)-OSU6162 to see if it could help people with ME/CFS feel less mentally tired. Sixty-two patients received either the drug or a placebo (dummy pill) for 2 weeks. While both groups felt somewhat better during treatment, the drug did not work significantly better than placebo overall. Interestingly, the drug appeared to help more in patients who were also taking antidepressants.

Evidence Atlas

Evidence browser

A randomised controlled trial of the monoaminergic stabiliser (-)-OSU6162 in treatment of myalgic encephalomyelitis/chronic fatigue syndrome.

Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): a double-blind, randomised study.

[Chronic fatigue syndrome treated with transcutaneous electrical acupoint stimulation: a randomized controlled trial].

Complementary and alternative healthcare use by participants in the PACE trial of treatments for chronic fatigue syndrome.

Treatment expectations influence the outcome of multidisciplinary rehabilitation treatment in patients with CFS.

Genetic variation in catechol-O-methyltransferase modifies effects of clonidine treatment in chronic fatigue syndrome.

A randomized, placebo-controlled, double-blinded trial of duloxetine in the treatment of general fatigue in patients with chronic fatigue syndrome.

[Moxibustion at Gaohuang (BL 43) for chronic fatigue syndrome: a randomized controlled trial].

The feasibility and acceptability of conducting a trial of specialist medical care and the Lightning Process in children with chronic fatigue syndrome: feasibility randomized controlled trial (SMILE study).

Moderators of the treatment response to guided self-instruction for chronic fatigue syndrome.

Mindfulness-based cognitive therapy for people with chronic fatigue syndrome still experiencing excessive fatigue after cognitive behaviour therapy: a pilot randomized study.

Recovery from chronic fatigue syndrome after treatments given in the PACE trial.

A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.

[Observation on therapeutic effect of acupuncture of Back-shu acupoints for chronic fatigue syndrome patients].

Amisulpride vs. fluoxetine treatment of chronic fatigue syndrome: a pilot study.

[Randomized controlled study on acupuncture treatment for chronic fatigue syndrome].

Guided self-instructions for people with chronic fatigue syndrome: randomised controlled trial.

Cognitive-behavioural therapy v. mirtazapine for chronic fatigue and neurasthenia: randomised placebo-controlled trial.

Is cognitive behaviour therapy for chronic fatigue syndrome also effective for pain symptoms?

The effect of acclydine in chronic fatigue syndrome: a randomized controlled trial.

Curated Collections

Neuroinflammation Evidence

Metabolism & Mitochondria

Biomarkers

PEM-Specific Research